Mahil, SK, Yates, M, Yiu, ZZN, Langan, SM, Tsakok, T, Dand, N, Mason, KJ, McAteer, H, Meynell, F, Coker, B, Vincent, A, Urmston, D, Vesty, A, Kelly, J, Lancelot, C, Moorhead, L, Bachelez, H, Capon, F, Contreras, CR, de la Cruz, C, Di Meglio, P, Gisondi, P, Jullien, D, Lambert, J, Naldi, L, Norton, S, Puig, L, Spuls, P, Torres, T, Warren, RB, Waweru, H, Weinman, J, Brown, MA, Galloway, JB, Griffiths, CM, Barker, JN, Smith, CH, PsoProtect Study Grp. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17450. PMID:34145643. IF:9.228(Q1/1D).

Reich, K, Hansen, JB, Puig, L, Konstantinou, MP, Warren, RB. Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17433. PMID:34076919. IF:9.228(Q1/1D).

Sanchez-Velazquez, A, Bauer-Alonso, A, Estrach, T, Vega-Diez, D, Garcia-Muret, P, Haya, L, Penate, Y, Acebo, E, de Misa, RF, Blanes, M, Suh-Oh, HJ, Izu, R, Silva-Diaz, E, Sarriugarte, J, Roman-Curto, C, Botella-Estrada, R, Mateu-Puchades, A, Prieto-Torres, L, Morillas, V, Morillo, M, Sanchez-Caminero, P, Calzado, L, Perez-Ferriols, A, Perez, A, Dominguez, JD, Navedo, M, Muniesa, C, Combalia, A, Arroyo-Andres, J, Descalzo, MA, Garcia-Doval, I, Ortiz-Romero, PL. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021; 35(10)DOI:10.1111/jdv.17430. PMID:34062018. IF:9.228(Q1/1D).

Rusinol, L, Amat-Samaranch, V, Baselga, E, Puig, L, Roe, E. Prepubertal retroareolar cysts. PEDIATRIC DERMATOLOGY. 2021; 38(5)DOI:10.1111/pde.14786. PMID:34514639. IF:1.997(Q3/7D).

Speeckaert, R, Lambert, J, Puig, L, Speeckaert, M, Lapeere, H, De Schepper, S, van Geel, N. Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?. DRUGS IN R&D. 2021; 21(3)DOI:10.1007/s40268-021-00349-0. PMID:34106430. IF:3.203(Q3/6D).

Iznardo, H, Vilarrasa, E, Lopez-Ferrer, A, Puig, L. Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(3)DOI:10.1111/bjd.20416. PMID:33913516. IF:11.113(Q1/1D).